- Home
- GRND vs ICUI Comparison
GRND vs ICUI Comparison
Compare GRND & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRND
- ICUI
- Stock Information
- Founded
- GRND 2009
- ICUI 1984
- Country
- GRND United States
- ICUI United States
- Employees
- GRND N/A
- ICUI N/A
- Industry
- GRND Computer Software: Prepackaged Software
- ICUI Medical/Dental Instruments
- Sector
- GRND Technology
- ICUI Health Care
- Exchange
- GRND Nasdaq
- ICUI Nasdaq
- Market Cap
- GRND 3.9B
- ICUI 3.6B
- IPO Year
- GRND N/A
- ICUI 1992
- Fundamental
- Price
- GRND $19.58
- ICUI $138.67
- Analyst Decision
- GRND Strong Buy
- ICUI Buy
- Analyst Count
- GRND 5
- ICUI 4
- Target Price
- GRND $20.00
- ICUI $199.67
- AVG Volume (30 Days)
- GRND 1.9M
- ICUI 340.0K
- Earning Date
- GRND 05-08-2025
- ICUI 05-06-2025
- Dividend Yield
- GRND N/A
- ICUI N/A
- EPS Growth
- GRND N/A
- ICUI N/A
- EPS
- GRND N/A
- ICUI N/A
- Revenue
- GRND $344,636,000.00
- ICUI $2,382,046,000.00
- Revenue This Year
- GRND $26.85
- ICUI $0.84
- Revenue Next Year
- GRND $22.31
- ICUI $2.91
- P/E Ratio
- GRND N/A
- ICUI N/A
- Revenue Growth
- GRND 32.71
- ICUI 5.44
- 52 Week Low
- GRND $8.95
- ICUI $93.36
- 52 Week High
- GRND $19.20
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- GRND 65.42
- ICUI 45.36
- Support Level
- GRND $16.18
- ICUI $136.61
- Resistance Level
- GRND $18.34
- ICUI $145.82
- Average True Range (ATR)
- GRND 0.93
- ICUI 10.06
- MACD
- GRND 0.18
- ICUI 0.10
- Stochastic Oscillator
- GRND 97.84
- ICUI 38.37
About GRND Grindr Inc.
Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.